Skip to main content

Table 5 NEW score

From: A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial

Physiologic parameters

Score

3

2

1

0

1

2

3

Respiratory rate

≤8

 

9–11

12–20

 

21–24

≥25

Oxygen saturation

≤91

92–93

94–95

≥96

   

Supplemental oxygen

 

Yes

 

No

   

Temperature

≤35.0

 

35.1–36.0

36.1–38.0

38.1–39.0

≥39.1

 

Systolic BP

≤90

91–100

101–110

111–219

  

≥220

Heart rate

≤40

 

41–50

51–90

91–110

111–130

≥131

Level of consciousness*

   

A

  

VPU

  1. *Level of consciousness: alert (A), arousable only to voice (V) or pain (P), and unresponsive (U)
Back to article page

Trials

ISSN: 1745-6215